Research Article

Separation and Quantification of Eight Antidiabetic Drugs on A High-Performance Liquid Chromatography: Its Application to Human Plasma Assay

Table 3

Stability data for anti-diabetic drugs in plasma.

DrugNominal concentrationSample conditions ( m e a n ± S . D )
ng/mLShort-term a Long-term b Freeze-thaw c
Nominal (%)RSDNominal (%)RSDNominal (%)RSD

ROS53.7103.16.297.58.6102.47.1
1531.099.32.098.02.298.71.7

PIO48.9102.05.997.18.8100.65.9
1513.899.02.097.21.999.11.8

GLP50.698.97.695.68.097.16.6
1498.599.31.598.71.499.80.9

GLC46.8105.78.799.63.4100.12.3
1467.097.82.097.34.198.14.5

REP49.2107.88.999.23.899.23.0
1502.7103.56.198.10.898.61.4

NGL52.998.911.196.77.296.95.3
1439.6108.06.499.04.898.52.8

GLB45.795.413.295.110.695.57.8
1452.097.810.196.86.896.25.9

GLM48.6103.711.699.11.998.72.2
1477.5106.36.098.72.398.61.0

a Exposed at room temperature for 24 h.
b Stored at −70°C.
c After three freeze-thaw cycles.